30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

NuVasive Launches New Orthobiologic Products -

NuVasive expanded its orthobiologic portfolio with U.S. launch of traditional bone allograft, Amniotic Membrane DS and additional form factors for the Propel™ DBM product line. Allograft is available as cancellous chips, demineralized cancellous chips, cortical cancellous chips and cancellous crushed in a range of grind sizes and volumes. Double-sided human Amniotic Membrane DS is intended to address adhesion prevention and scar tissue formation. Propel DBM now includes gel, gel plus and putty plus as additional form factors to address surgeon preference. Gel is delivered in a syringe, and putty plus and gel plus contain cancellous chips for additional osteoconductive properties. The Propel line also includes fibers. (NuVasive, Inc., 9/24/18)